SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natural Biocon (India) Ltd (543207)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543207 NSE: Trading | Small Cap | Natural Biocon (I) Share Price

₹3.39 -0.04 (-1.17%)

As on 10-Jun'26 16:59

Natural Biocon (India) Ltd (543207)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543207 NSE: Trading | Small Cap | Natural Biocon (I) Share Price

₹3.39 -0.04 (-1.17%)

As on 10-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹9 Cr.
Current Price
₹3.4
52-Week Low / High
₹3 / 16
TTM EPS
₹-0
TTM Sales
₹2.5 Cr.
Book Value per Share
₹11.9
P/E Ratio
0.00
Lower than its 5-year historical median
Industry PE
35.7
Price to Book (P/B)
0.28
Lower than its 5-year historical median
Price to Sales (P/S)
3.44
Lower than its 5-year historical median
EV/EBITDA
-245.31
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
0.20%
Underperforms industry median
Return on Capital Employed (ROCE)
0.27%
Underperforms industry median
Return on Assets (ROA)
0.16%
Operating Profit Margin
0.7%
Net Profit Margin
0.53%
Gross Profit Margin
0.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-38.29%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-73.91%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-73.33%
Asset Quality
Promoter Holding
9.36%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹6 Cr.
Equity
₹25.8 Cr.
Face Value
₹10
All Time Low / High
₹3.09 / 34.15

Natural Biocon (India) stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Natural Biocon (India) Ltd a good quality company?
Natural Biocon (India) Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Natural Biocon (India) Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Natural Biocon (India) Ltd vs industry peers?
Natural Biocon (India) Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Natural Biocon (India) Ltd?
Promoters hold 9.36% of the Natural Biocon (India) Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Natural Biocon (India) Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -25.89% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Natural Biocon (India) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 1%8.6%1%-0.3%0%0.7%2%1.8%0.3%-
Value Creation
Index
-0.9-0.4-0.9-1.0-1.0-1.0-0.9-0.9-1.0-

Growth Parameters

Sales 0.210.500.10.51.313.58.43
Sales YoY Gr.-593.3%-56.7%-100%NA269.2%160.4%982.4%-38.3%-
Adj EPS 0.10.60.1-000.10.20.10-0
YoY Gr.-785.7%-90.3%-150%NANA166.7%-18.8%-84.6%-
BVPS (₹) 1010.610.610.510.510.610.810.912.411.9
Adj Net
Profit
0.10.70.1-000.10.20.20-0
Cash Flow from Ops. 0.2-0-0.90.20.30.20.2-0.11.3-
Debt/CF from Ops. 00-14.41.10.90.7-0.50.2-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA159.1%-38.3%
Adj EPS NANA-30.7%-84.6%
BVPSNA3.2%5.3%13.5%
Share Price - -26.3% -18.4% -74.6%

Key Financial Parameters

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.760.6-0.300.61.51.20.2-0.2
Op. Profit
Mgn %
70.7962503.218.419.81.70.71.8
Net Profit
Mgn %
49.567.216.202.113.714.31.10.5-2
Debt to
Equity
000.10.1000000
Working Cap
Days
02,9737,607025,5046,7582,708312598134
Cash Conv.
Cycle
019877601,7234121971319-22

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0.151.040.4500.130.481.2513.538.35
Operating Expenses + 0.050.040.340.030.130.391.0113.318.29
Manufacturing Costs000.0100000.080.05
Material Costs0.040000.090.290.8812.677.39
Employee Cost 000.020.020.010.020.050.190.32
Other Costs 0.010.040.300.020.030.080.080.370.53
Operating Profit 0.1110.11-0.0300.090.250.230.06
Operating Profit Margin (%) 70.7%96.0%25.0%-3.2%18.4%19.8%1.7%0.7%
Other Income + 000.01000000
Exceptional Items 000000000
Interest 000000000
Depreciation 000000000
Profit Before Tax 0.1110.12-0.0300.090.250.230.06
Tax 0.030.300.05000.020.070.070.02
Profit After Tax 0.080.700.07-0.0300.070.180.150.04
PAT Margin (%) 49.5%67.2%16.2%-2.1%13.7%14.3%1.1%0.5%
Adjusted EPS (₹)0.10.60.1-0.00.00.10.20.10.0
Dividend Payout Ratio (%)74.90%8.10%78.40%0%0%0%0%0%0%

Valuation of Natural Biocon (I) - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 11.3812.0112.0111.9811.9912.0512.2312.3831.87
Share Capital 11.3711.3711.3711.3711.3711.3711.3711.3725.78
Reserves 0.010.640.640.610.610.680.861.016.09
Debt +000.820.680.360.170.150.070.28
Long Term Debt000000000
Short Term Debt000.820.680.360.170.150.070.28
Minority Interest000000000
Trade Payables000000.021.024.095.47
Others Liabilities 0.130.420.180.050.040.050.120.220.90
Total Liabilities 11.5112.4313.0212.7112.3812.3013.5216.7738.52

Fixed Assets

Net Fixed Assets +000000.010.010.010
Gross Block000000.010.010.010.01
Accumulated Depreciation000000000.01
CWIP 3.293.293.293.293.293.293.293.293.29
Investments 0000000021.12
Inventories0.060.060.060.060.060.060.920.160.17
Trade Receivables01.020.780.620.520.490.634.875.66
Cash Equivalents 0.240.130.030.030.040.210.400.190.05
Others Assets 7.927.938.878.718.488.248.288.258.23
Total Assets 11.5112.4313.0212.7112.3812.3013.5216.7738.52

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 0.21-0.04-0.860.150.320.190.21-0.121.30
PBT 0.1110.12-0.0300.090.250.230.06
Adjustment 00000000-0
Changes in Working Capital 0.14-0.74-0.930.180.320.110.03-0.281.26
Tax Paid -0.03-0.30-0.050-0-0.01-0.07-0.07-0.02
Cash Flow From Investing Activity + 00000000-21.11
Capex 000000000
Net Investments 00000000-21.12
Others 000000000.01
Cash Flow From Financing Activity + -0.07-0.070.75-0.14-0.32-0.02-0.02-0.0919.67
Net Proceeds from Shares 0000000019.45
Net Proceeds from Borrowing 000.82-0.14-0.32-0.15-0.02-0.090
Interest Paid 000000000
Dividend Paid -0.06-0.06-0.06000000
Others -0.01-0.01-0.01000.13000.22
Net Cash Flow 0.15-0.11-0.110.0100.170.19-0.21-0.14

Financial Ratio

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.675.990.6-0.260.020.551.481.240.2
ROCE (%)0.958.560.98-0.250.030.722.021.820.27
Asset Turnover Ratio0.010.090.0400.010.040.10.890.3
PAT to CFO Conversion(x)2.63-0.06-12.29N/AN/A2.711.17-0.832.5
Working Capital Days
Receivable Days0357.50730.9001,569.90382.8016374.20230.40
Inventory Days131.3019.3044.900152.9041.80141.3014.507.20
Payable Days0000028.60215.6073.60236

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Natural Biocon (India) Ltd FAQs

The current trading price of Natural Biocon (I) on 10-Jun-2026 16:59 is ₹3.39.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Jun-2026 the market cap of Natural Biocon (I) stood at ₹8.74 Cr

The latest P/E ratio of Natural Biocon (I) as of 09-Jun-2026 is 0.00.

The latest P/B ratio of Natural Biocon (I) as of 09-Jun-2026 is 0.28.

The 52-week high of Natural Biocon (I) is ₹15.97 and the 52-week low is ₹3.09.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Natural Biocon (I) is ₹2.54 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Natural Biocon (India) Ltd is a below average quality company.

The key valuation ratios of Natural Biocon (India) Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Natural Biocon (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Natural Biocon (India) Ltd

Natural Biocon (India) Limited is a listed public limited company incorporated in 1992. Its shares are listed on Bombay Stock Exchanges. The company operates in business of natural extract and chemical trading. The Company’s principal revenue stream is retail trading of agricultural produce and commodities.

Business area of the company

The company is engaged in the business of chemicals, natural extracts and agricultural produces.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×